Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Clinical Medicine & Research|October 28, 2011
Comparing outcomes of HIV versus non-HIV patients requiring mechanical ventilationVikas Pathak, Iliana Samara Hurtado Rendon, Shebli Atrash, et al.
Life (Basel, Switzerland)|March 28, 2024
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)Hamid Ehsan, Myra Robinson, Peter M Voorhees, et al.
Cancers|September 14, 2024
Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple MyelomaBarry Paul, Faiz Anwer, Shahzad Raza, et al.
European Journal of Haematology|August 11, 2021
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM)Dante Pennipede, Ghulam Rehman Mohyuddin, Ryan Hawkins, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2023
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)Hamid Ehsan, Alec Britt, Peter M Voorhees, et al.
European Journal of Haematology|July 10, 2022
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccinationAl-Ola Abdallah, Zahra Mahmoudjafari, Tahani Atieh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 12, 2019
A Review of Growth Factor Support in Bloodless Autologous Hematopoietic Stem Cell TransplantJennifer C Zhao, Justin R Arnall, Allison L Martin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug-Based RegimensJai N Patel, Myra Robinson, Megan Jagosky, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Evaluation of Montelukast for the Prevention of Infusion-related Reactions With DaratumumabDonald C Moore, Justin R Arnall, Daniel L Thompson, et al.
Blood|December 4, 2024
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myelomaDan T Vogl, Shebli Atrash, Sarah A Holstein, et al.
Pageof 9